129 related articles for article (PubMed ID: 12507918)
1. Clonal origin and expansions in neoplasms: biologic and technical aspects must be considered together.
Pozo-Garcia L; Diaz-Cano SJ
Am J Pathol; 2003 Jan; 162(1):353-4; author reply 354-5. PubMed ID: 12507918
[No Abstract] [Full Text] [Related]
2. Exploring and exploiting instability.
Teixeira da Costa L; Lengauer C
Cancer Biol Ther; 2002; 1(3):212-25. PubMed ID: 12432267
[TBL] [Abstract][Full Text] [Related]
3. Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia.
Crescenzi B; Sacchi S; Marasca R; Temperani P; La Starza R; Matteucci C; Bonacorsi G; Romoli S; Martelli MF; Mecucci C; Emilia G
Leukemia; 2002 May; 16(5):955-6. PubMed ID: 11986962
[No Abstract] [Full Text] [Related]
4. Tumors with microsatellite instability: many mutations, targets and paradoxes.
Perucho M
Oncogene; 2003 Apr; 22(15):2223-5. PubMed ID: 12700658
[No Abstract] [Full Text] [Related]
5. Microsatellite instability.
de la Chapelle A
N Engl J Med; 2003 Jul; 349(3):209-10. PubMed ID: 12867603
[No Abstract] [Full Text] [Related]
6. "Attack of the Clones": Commonalities Between Cancer and Atherosclerosis.
DiRenzo D; Owens GK; Leeper NJ
Circ Res; 2017 Feb; 120(4):624-626. PubMed ID: 28209794
[TBL] [Abstract][Full Text] [Related]
7. Colorectal adenoma and cancer divergence. Evidence of multilineage progression.
Tsao JL; Tavaré S; Salovaara R; Jass JR; Aaltonen LA; Shibata D
Am J Pathol; 1999 Jun; 154(6):1815-24. PubMed ID: 10362806
[TBL] [Abstract][Full Text] [Related]
8. Developing Cures: Targeting Ontogenesis in Cancer.
Lin VTG; Pruitt HC; Samant RS; Shevde LA
Trends Cancer; 2017 Feb; 3(2):126-136. PubMed ID: 28718443
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous occurrence of myelodysplastic syndrome and monoclonal B lymphocytes with a different clonal origin.
Cauwelier B; Nollet F; De Laere E; Van Leeuwen M; Billiet J; Criel A; Louwagie A
Leuk Lymphoma; 2002 Jan; 43(1):191-3. PubMed ID: 11908728
[TBL] [Abstract][Full Text] [Related]
10. Accurate reconstruction of the temporal order of mutations in neoplastic progression.
Sprouffske K; Pepper JW; Maley CC
Cancer Prev Res (Phila); 2011 Jul; 4(7):1135-44. PubMed ID: 21490131
[TBL] [Abstract][Full Text] [Related]
11. Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations.
Rycaj K; Tang DG
Cancer Res; 2015 Oct; 75(19):4003-11. PubMed ID: 26292361
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics: Through the cracked lens of cancer genomes.
Zuccala E
Nat Rev Genet; 2016 Jan; 17(1):7. PubMed ID: 26593422
[No Abstract] [Full Text] [Related]
13. Cell biology of precancer.
Pontén J
Cancer Surv; 1998; 32():5-35. PubMed ID: 10489621
[No Abstract] [Full Text] [Related]
14. [Cancer cells. Genetic anomalies (oncogenes and anti-oncogenes), growth factors, apoptosis and dissemination, prognostic impact].
Blay JY; Puisieux A
Rev Prat; 2000 May; 50(10):1135-44. PubMed ID: 10905101
[No Abstract] [Full Text] [Related]
15. Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
Prick J; de Haan G; Green AR; Kent DG
Exp Hematol; 2014 Oct; 42(10):841-51. PubMed ID: 25201757
[TBL] [Abstract][Full Text] [Related]
16. Clonal dynamics of progressive neoplastic transformation.
Chow M; Rubin H
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6976-81. PubMed ID: 10359824
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for cytogenetic investigations in tumours.
Hastings RJ; Bown N; Tibiletti MG; Debiec-Rychter M; Vanni R; Espinet B; van Roy N; Roberts P; van den Berg-de-Ruiter E; Bernheim A; Schoumans J; Chatters S; Zemanova Z; Stevens-Kroef M; Simons A; Heim S; Salido M; Ylstra B; Betts DR; ;
Eur J Hum Genet; 2016 Jan; 24(1):6-13. PubMed ID: 25804401
[No Abstract] [Full Text] [Related]
18. [Clone war: tumour-suppressive cell competition].
De Flori C; Walter A; El Moumen Kassoussi A; Mignotte B
Med Sci (Paris); 2017; 33(6-7):609-612. PubMed ID: 28990562
[No Abstract] [Full Text] [Related]
19. [Continuous influx of newly transformed cells as a source of tumor clonal heterogeneity].
Likhtenshteĭn AV
Vopr Onkol; 2007; 53(5):596-7. PubMed ID: 18154128
[No Abstract] [Full Text] [Related]
20. Intratumor heterogeneity in evolutionary models of tumor progression.
Durrett R; Foo J; Leder K; Mayberry J; Michor F
Genetics; 2011 Jun; 188(2):461-77. PubMed ID: 21406679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
